Rothman RB[au] - Search Results

Year	Number of Results
1979	1
1981	1
1982	4
1983	6
1984	7
1985	5
1986	7
1987	10
1988	8
1989	16
1990	19
1991	9
1992	14
1993	10
1994	16
1995	21
1996	17
1997	10
1998	23
1999	21
2000	17
2001	13
2002	19
2003	14
2004	13
2005	12
2006	22
2007	17
2008	18
2009	16
2010	9
2011	14
2012	11
2013	9
2014	7
2015	5
2017	1
2018	1
2019	1
2022	0

1

Retraction and apology: Is phentermine an inhibitor of monoamine oxidase?

Rothman RB. Rothman RB. Synapse. 1999 Jul;33(1):81; discussion 82. doi: 10.1002/(SICI)1098-2396(199907)33:1<81::AID-SYN8>3.0.CO;2-Z. Synapse. 1999. PMID: 10400539 No abstract available.

2

Serotonergic drugs and valvular heart disease.

Rothman RB, Baumann MH. Rothman RB, et al. Expert Opin Drug Saf. 2009 May;8(3):317-29. doi: 10.1517/14740330902931524. Expert Opin Drug Saf. 2009. PMID: 19505264 Free PMC article. Review.

3

Phentermine cardiovascular safety.

Rothman RB, Hendricks EJ. Rothman RB, et al. Am J Emerg Med. 2009 Oct;27(8):1010-3. doi: 10.1016/j.ajem.2009.07.014. Am J Emerg Med. 2009. PMID: 19857423 No abstract available.

4

Monoamine transporters and psychostimulant drugs.

Rothman RB, Baumann MH. Rothman RB, et al. Eur J Pharmacol. 2003 Oct 31;479(1-3):23-40. doi: 10.1016/j.ejphar.2003.08.054. Eur J Pharmacol. 2003. PMID: 14612135 Review.

5

Salvinorin A analogs as probes in opioid pharmacology.

Prisinzano TE, Rothman RB. Prisinzano TE, et al. Among authors: rothman rb. Chem Rev. 2008 May;108(5):1732-43. doi: 10.1021/cr0782269. Chem Rev. 2008. PMID: 18476672 Free PMC article. Review. No abstract available.

6

Appetite suppressants, cardiac valve disease and combination pharmacotherapy.

Rothman RB, Baumann MH. Rothman RB, et al. Am J Ther. 2009 Jul-Aug;16(4):354-64. doi: 10.1097/MJT.0b013e31817fde95. Am J Ther. 2009. PMID: 19092640 Free PMC article. Review.

7

Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.

Cunningham CW, Rothman RB, Prisinzano TE. Cunningham CW, et al. Among authors: rothman rb. Pharmacol Rev. 2011 Jun;63(2):316-47. doi: 10.1124/pr.110.003244. Epub 2011 Mar 28. Pharmacol Rev. 2011. PMID: 21444610 Free PMC article. Review.

8

Dopamine/serotonin releasers as medications for stimulant addictions.

Rothman RB, Blough BE, Baumann MH. Rothman RB, et al. Prog Brain Res. 2008;172:385-406. doi: 10.1016/S0079-6123(08)00919-9. Prog Brain Res. 2008. PMID: 18772043 Review.

9

Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter.

Reith ME, Blough BE, Hong WC, Jones KT, Schmitt KC, Baumann MH, Partilla JS, Rothman RB, Katz JL. Reith ME, et al. Among authors: rothman rb. Drug Alcohol Depend. 2015 Feb 1;147:1-19. doi: 10.1016/j.drugalcdep.2014.12.005. Epub 2014 Dec 18. Drug Alcohol Depend. 2015. PMID: 25548026 Free PMC article. Review.

10

Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates.

Schmitt KC, Rothman RB, Reith ME. Schmitt KC, et al. Among authors: rothman rb. J Pharmacol Exp Ther. 2013 Jul;346(1):2-10. doi: 10.1124/jpet.111.191056. Epub 2013 Apr 8. J Pharmacol Exp Ther. 2013. PMID: 23568856 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results